Antidepressant Maker Seaport Raises $255 Million in Upsized IPO

Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range.
Source
Bloomberg Markets
Opens original article in a new tab
